| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 6,656 | $16.97 | $112,952.32 | -2.9% | +62.4% | +255.3% | |
| Jun 4, 2025 | PCRX Pacira Biosciences, Inc. | Riker Lauren76 | Senior Vice President, Finance | Sell | 5,578 | $26.21 | $146,208.16 | -8.6% | +0.9% | -16.0% | |
| Jun 4, 2025 | LQDA Liquidia Corp | Schundler Russell58 | General Counsel | Sell | 8,460 | $16.97 | $143,566.20 | -1.4% | +62.4% | +255.3% | |
| Jun 4, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 7,597 | $16.97 | $128,921.09 | -2.7% | +62.4% | +255.3% | |
| Jun 4, 2025 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 3,597 | $16.97 | $61,041.09 | -1.8% | +62.4% | +255.3% | |
| Jun 4, 2025 | LQDA Liquidia Corp | Jeffs Roger66 | Chief Executive Officer | Sell | 30,610 | $16.97 | $519,451.70 | -2.8% | +62.4% | +255.3% | |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 18,299 | $28.80 | $527,011.20 | -40.4% | +17.8% | +66.4% | |
| Jun 3, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Shields Matthew | EVP, Global Operations | Sell | 6,206 | $17.02 | $105,627.98 | -38.3% | +9.1% | +101.5% | |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Megna Michael R | Chief Accounting Officer | Sell | 15,211 | $28.75 | $437,316.25 | -31.9% | +17.8% | +66.4% | |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Moat Ross | Chief Commercial Officer | Sell | 27,594 | $29.02 | $800,777.88 | -74.6% | +17.8% | +66.4% | |
| Jun 3, 2025 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 652 | $170.00 | $110,840.00 | -4.1% | -10.2% | -54.4% | |
| Jun 3, 2025 | VREOF Vireo Growth Inc. | Chicago Atlantic Opportunity Portfolio, LP | 10% Owner | Buy | 182,700 | $0.40 | $72,961.92 | +0.3% | - | - | |
| Jun 2, 2025 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 12,000 | $325.82 | $3,909,893.25 | -18.6% | +24.4% | +67.3% | |
| Jun 2, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $25.67 | $12,835.05 | -0.7% | +21.4% | -27.3% | |
| Jun 2, 2025 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | Director | Sell | 26,066 | $76.83 | $2,002,570.46 | -3.8% | -28.3% | +25.9% | |
| Jun 2, 2025 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 859 | $16.74 | $14,379.66 | -0.2% | +69.4% | +248.2% | |
| Jun 2, 2025 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 451 | $16.74 | $7,549.74 | -0.2% | +69.4% | +248.2% | |
| Jun 2, 2025 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 581 | $16.74 | $9,725.94 | -0.3% | +69.4% | +248.2% | |
| Jun 2, 2025 | LQDA Liquidia Corp | Schundler Russell58 | General Counsel | Sell | 923 | $16.74 | $15,451.02 | -0.2% | +69.4% | +248.2% | |
| May 30, 2025 | CWBHF Charlotte's Web Holdings, Inc. | Kunkel Raymond J. | Chief Operating Officer | Buy | 227,273 | $0.11 | $24,878.13 | +18.6% | - | - | |
| May 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 168 | $5.11 | $857.68 | - | -30.0% | +24.0% | |
| May 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 945 | $5.11 | $4,824.45 | - | -30.0% | +24.0% | |
| May 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 84 | $5.11 | $428.84 | - | -30.0% | +24.0% | |
| May 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 168 | $5.11 | $857.68 | - | -30.0% | +24.0% | |
| May 29, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $316.07 | $3,476,765.35 | -4.3% | -4.7% | +73.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.